Endocrinology diagnostics IDS and EUROIMMUN. Hypertension Adrenal Funcion Growth Bone metabolism Reproduction
Products

HAND IN HAND FOR POWERFUL ENDOCRINOLOGY – Test systems backed up by extensive scientific studies for the assessment of disorders and diseases of the adrenal glands, combining quality and progress

Abnormally elevated blood pressure (hypertension, HT) is a major cause of premature death and a challenge worldwide, with an estimated number of >1 billion adults aged 30–79 years having hypertension, many of them unaware of being affected. Unfortunately, HT can be a symptom of various diseases with very different causes, making diagnostics difficult. The adrenal […]

Science

Line blot for myositis shows high agreement with biopsy

A multiparameter EUROLINE blot for detection of myositis-related autoantibodies showed a high agreement with muscle biopsy results in patients with idiopathic inflammatory myopathies (IIM), suggesting it can be used as a first-line diagnostic tool in the diagnostic workflow. The recently published study was performed as part of a collaboration between scientists from EUROIMMUN Brazil and

Science

Role of Epstein-Barr virus in multiple sclerosis

The frequency of intrathecal antibody production to Epstein-Barr virus (EBV) in multiple sclerosis (MS) patients is surprisingly low compared to that of other microbial agents. This was shown in a collaborative study between EUROIMMUN and scientists at Charité Universitätsmedizin Berlin. The finding is intriguing given the strong link between EBV and MS. EBV is presumed

Products

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Press release, March 3rd 2025 Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus. EUROIMMUN’s Anti-Measles Virus ELISA 2.0 (IgG) is the first of several assays in development expanding EUROIMMUN’s

Scroll to Top